News
MOVES is a new multicenter clinical essay involving 560 patients from Spain, Germany, France and Poland.The aim of the MOVES project (Multicenter Osteoarthritis InterVEntion trial with Sysadoas) is to contribute further evidence of the efficacy and security of the combination of chondroitin sulfate and glucosamine in the treatment of knee osteoarthritis patients with moderate to severe pain.
Osteoarthritis causes 35% of primary care visitsPrimary care physicians should play a key role in the diagnosis and treatment of osteoarthritis in order to improve its symptoms (pain, functional disability) and to delay its progression
The decrease in estrogen levels caused by the arrival of menopause is one of the risk factors for the development of osteoarthritis. Gynecologists are now beginning to diagnose and treat post menopausal osteoarthritis. Osteoarthritis in menopausal women is under diagnosed, and affects negatively their quality of life.
* Scientific and educational activities and the dissemination of information on communal activities will be the two main pillars of the agreement.* The objectives of the PACAP are to encourage healthy lifestyles, disseminate information related to health issues, and to improve the quality of life and the social welfare level of the population.
Bioibérica Farma, the only Spanish company specializing in the treatment of osteoarthritis, launches an osteoarthritis awareness campaign. According to the World Health Organization (WHO), osteoarthritis is the fourth most common cause of loss of Quality Adjusted Life Years.